Strategic Partnerships Gossamer Bio has established collaborations with industry leaders like Chiesi Group, indicating potential partnership and sales opportunities for the company's innovative treatments.
Clinical Development Updates Recent updates on Gossamer Bio's clinical studies, such as the TORREY Study and PROSERA Study, present opportunities to engage with healthcare providers and institutions for future product sales.
Key Personnel Addition The appointment of Steven D. Nathan, M.D., and Skye Drynan to the Board of Directors signifies a strategic move that could open doors for new business relationships and sales channels.
Investment Boost The recent $5.11 million investment by SilverArc Capital Management indicates potential growth and expansion, offering opportunities for sales in line with the company's financial backing.
Industry Relationship Gossamer Bio's focus on developing lung health solutions aligns with market trends and positions the company for sales opportunities within the growing respiratory disease treatment sector.
51
$10M$50M
128$10M$50M
210$10M$50M
65$10M$50M
11$10M
29
35$10M
122$10M$50MGossamer Bio uses 8 technology products and services including Drupal, React, PWA, and more. Explore Gossamer Bio's tech stack below.
| Gossamer Bio Email Formats | Percentage |
| FLast@gossamerbio.com | 87% |
| FirstLast@gossamerbio.com | 6% |
| First.Last@gossamerbio.com | 5% |
| LFirst@gossamerbio.com | 2% |
Biotechnology ResearchCalifornia, United States51-200 Employees
Gossamer Bio is a San Diego-based clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension. Our goal is to enhance the lives of people living with pulmonary hypertension.
Company Overview
Media & News
Funding & FinancialsGossamer Bio has raised a total of $212M of funding over 5 rounds. Their latest funding round was raised on Jul 20, 2023 in the amount of $212M.
Gossamer Bio's revenue is in the range of $10M$50M
Funding & FinancialsGossamer Bio has raised a total of $212M of funding over 5 rounds. Their latest funding round was raised on Jul 20, 2023 in the amount of $212M.
Gossamer Bio's revenue is in the range of $10M$50M
1-888-653-2347 
support@leadiq.com